Healthcare Services

Anemia In Elderly Market Global Report 2026 Market Expected to Record Steady Growth and Approach $4.59 Billion by 2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Anemia In Elderly Market By The End Of 2030?

The market size for anemia in elderly has experienced robust growth in recent years. It is projected to increase from $2.99 billion in 2025 to $3.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been influenced by factors such as the growing aging population, the increased occurrence of chronic diseases, the widespread availability of oral iron supplements, the broadening of hospital-based anemia management, and a rising awareness of nutritional deficiencies.

The anemia in elderly market size is projected to experience substantial growth in the upcoming years. This market is anticipated to expand to $4.59 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is fueled by factors such as the increasing demand for personalized anemia treatment, greater adoption of long-acting injectables, a heightened focus on geriatric healthcare, the broadening of outpatient anemia management services, and improved diagnostic screening in elderly care settings. Significant trends expected in the same period include a rising embrace of combination therapy approaches, increased utilization of injectable iron treatments, a growing emphasis on early diagnosis within elderly populations, the expansion of home-based treatment options, and an enhanced focus on managing anemia associated with chronic diseases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Anemia In Elderly Market?

The expansion of the elderly demographic is anticipated to stimulate the future growth of the anemia in the elderly market. This refers to the rising count and percentage of individuals aged 65 and above, either within a specific society or worldwide. Several factors contribute to this demographic increase, such as longer life expectancies, decreasing birth rates, and the aging of large generational groups. An expanding older population leads to a greater occurrence of age-related and long-term health issues, which are major contributors to anemia among seniors. Consequently, this fuels the need for diagnosing, managing, and treating anemia, thereby boosting market expansion. For example, data from January 2024, provided by the Population Reference Bureau, a Nonprofit organization based in Kenya, projects that the American population aged 65 and above will increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Furthermore, this demographic’s proportion of the total population is forecasted to climb from 17% to 23% over the identical timeframe. Thus, the expanding senior demographic is a key impetus behind the growth of the anemia in the elderly market.

Which Segment Classifications Shape The Anemia In Elderly Market?

The anemia in elderly market covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

How Are Trends Impacting The Anemia In Elderly Market?

Leading companies operating in the anemia in the elderly market are concentrating on technological advancements, such as tailored treatments, to optimize treatment processes, enhance patient outcomes, minimize side effects, and improve overall healthcare efficiency. Individualized therapies are medical interventions formulated based on each patient’s unique characteristics. For example, in March 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company, declared the introduction of Redshot FCM, an innovative iron injection created to manage iron deficiency anemia for individuals who cannot tolerate oral iron. This intravenous iron preparation provides sufficient quantities of iron and exhibits an excellent safety profile. The injection utilizes an advanced Ferric Carboxymaltose formulation that enhances iron delivery and absorption. Redshot FCM illustrates a commitment to bettering healthcare by developing personalized therapies that consider individual patient specifics, resulting in improved treatment results for iron deficiency anemia.

Which Companies Are Expanding Their Footprint In The Anemia In Elderly Market?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Read the full anemia in elderly market report here:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Regions Are Projected To Dominate The Anemia In Elderly Market In The Coming Years?

North America was the largest region in the anemia in elderly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anemia In Elderly Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

Browse Through More Reports Similar to the Global Anemia In Elderly Market 2026, By The Business Research Company

chemotherapy induced anemia global market report

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

aplastic anemia global market report

https://www.thebusinessresearchcompany.com/report/aplastic-anemia-global-market-report

anosmia global market report

https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795